AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021
February 16 2021 - 12:00PM
Applied Genetic Technologies Corporation (Nasdaq: AGTC), a
biotechnology company conducting human clinical trials of
adeno-associated virus (AAV)-based gene therapies for the treatment
of rare diseases, today announced that Sue Washer, President &
Chief Executive Officer, will participate at the OIS Gene
Therapy Innovation Showcase, taking place virtually on Thursday,
February 18, 2021 from 12:00 PM to 3:00 PM CST.
The event will include a market overview and start-up spotlight,
followed by a panel discussion featuring recognized experts in the
field. The panel will highlight unique perspectives on gene therapy
in the eye care sector and product viability.
Event registration is complimentary. To register, visit:
https://hopin.com/sign_up
About AGTCAGTC is a clinical-stage
biotechnology company developing genetic therapies for people with
rare and debilitating ophthalmic, otologic and central nervous
system (CNS) diseases. AGTC is a leader in designing and
constructing all critical gene therapy elements and bringing them
together to develop customized therapies that address real patient
needs. AGTC’s most advanced clinical programs leverage its
best-in-class technology platform to potentially improve vision for
patients with an inherited retinal disease. AGTC has active
clinical trials in X-linked retinitis pigmentosa (XLRP) and
achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs
build on the Company’s industry-leading AAV manufacturing
technology and scientific expertise. AGTC is advancing multiple
important pipeline candidates to address substantial unmet clinical
need in optogenetics, otology and CNS disorders.
IR/PR Contacts:David Carey (IR)
or Tom Vickery (PR)FINN PartnersT: (212) 867-1768 or
(646)
871-8482david.carey@finnpartners.com or tom.vickery@finnpartners.com
Corporate Contacts:Bill SullivanChief Financial
OfficerApplied Genetic Technologies CorporationT: (617)
843-5728bsullivan@agtc.com
Stephen PotterChief Business OfficerApplied Genetic Technologies
CorporationT: (617) 413-2754spotter@agtc.com
Applied Genetic Technolo... (NASDAQ:AGTC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied Genetic Technolo... (NASDAQ:AGTC)
Historical Stock Chart
From Apr 2023 to Apr 2024